perfosfamide has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambinder, RF; Blackford, AL; Davis-Sproul, JM; Gocke, CD; Gore, SD; Jones, RJ; Kasamon, YL; Seifter, EJ | 1 |
| Biggs, D; Buzby, G; Edelstein, M; Magee, D; Mangan, P; Powlis, W; Sachs, B; Silberstein, L; Stadtmauer, E | 1 |
| Abella, E; Cummings, G; Karanes, C; Lum, LG; Momin, F; Ratanatharathorn, V; Sensenbrenner, LL; Uberti, J | 1 |
| Griffin, CA; Piantadosi, S; Rowley, S; Santos, G; Shah, NK; Wingard, JR | 1 |
| Bearman, SI; Cagnoni, PJ; Capizzi, R; Franklin, WA; Hami, L; Jones, RB; Ross, M; Schein, PS; Shpall, EJ | 1 |
| Ball, J; Bird, JM; Edelstein, M; Luger, S; Mangan, P; Powlis, W; Schultz, DJ; Silberstein, L; Stadtmauer, EA | 1 |
4 trial(s) available for perfosfamide and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Follow-Up Studies; Humans; Leukemia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2011 |
4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Recurrence; Transplantation, Autologous | 1994 |
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Probability; Prognosis; Prospective Studies; Survival Analysis; Time Factors; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Use of amifostine in bone marrow purging.
Topics: Adult; Amifostine; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Premedication; Treatment Outcome | 1996 |
2 other study(ies) available for perfosfamide and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Purging; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Female; Hodgkin Disease; Humans; Karyotyping; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
Topics: Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Transplantation, Autologous | 1996 |